Stay updated on Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision: v3.6.5 has been added, replacing the previous v3.6.4. This indicates a new revision of the page, without changes to the substantive study content.
    Difference
    0.0%
    Check dated 2026-08-08T23:34:02.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a newer build of the page. This change is a backend/version update and does not modify the study details or user-visible content.
    Difference
    0.0%
    Check dated 2026-07-25T16:52:05.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3. This reflects a minor update to the page's versioning, not a change to visible content.
    Difference
    0.1%
    Check dated 2026-07-04T05:12:48.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A new revision tag Revision: v3.6.2 was added, replacing the previous v3.6.0 tag.
    Difference
    0.0%
    Check dated 2026-06-27T04:14:39.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Publications section added with a PubMed-cited article related to the study, and a note that such publications are automatically populated from PubMed.
    Difference
    0.2%
    Check dated 2026-06-20T04:47:09.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Enrollment status updated to indicate recruitment is closed, signaling that the study will no longer seek new participants.
    Difference
    0.5%
    Check dated 2026-06-13T00:25:45.000Z thumbnail image

Stay in the know with updates to Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.